Coronavirus (COVID-19) – Guidance for patients receiving services from CereHealth Corp.

Our hearts and thoughts go out to all the individuals and families across the globe who have been affected, both directly and indirectly, by COVID-19. We appreciate the healthcare workers, local communities, and the governments around the world who are on the front line working to contain this coronavirus.

With You in Mind

We recognize that COVID-19 has required all of us to be more mindful as we go through our regular daily activities. At CereScan, our core value-system centers around us being patient-centric in every endeavor. Thus, with the best interest of the patient in mind, we want to address the needs of all those who are in need of medical procedures during this unprecedented time. We are closely monitoring recommendations from the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) as we strive to help protect our patients and team members. We are committed to taking appropriate actions and providing reliable information to our patients and our healthcare providers as it comes available.

No Preventative Measure Left Undone

Ahead of any of your visits to our CereScan clinic, you can have confidence that we are taking every recommended measure to continue providing you with unparalleled care during this challenging time. From handwashing hygiene to the cleaning product specifications for our injection rooms and camera room, every safety measure is being taken with you in mind. In short, while thanking all of you who continually put your trust in our dedicated clinical staff, we want to unequivocally communicate to you that every precaution and health measure is being taken by CereScan to ensure that your imaging appointments are not disrupted by the COVID-19 virus.

What We Know

With the latest announcements from the President of the United States and the ongoing updates from the CDC and WHO concerning the spread of COVID-19, everywhere we look, someone is talking about COVID-19. However, despite all of the constant COVID-19 dialogue, there has been very limited input into how this will impact those like you who are receiving imaging evaluations. As such, CereScan is committed to providing patients with up-to-date guidance from the best available resources across the globe. As new information becomes available, CereScan will continue to provide clarity, policy, and routine updates to ensure every patient feels confident and safe as they enter our facilities for treatment.

At CereScan, in agreement with the CDC (see CDC guidelines HERE), we recommend that our patients follow the below practical guidelines to reduce the risk of spreading or contracting COVID-19:

· Wash your hands often with soap and water for at least 20 seconds.

· If water and soap are not available, you can use hand sanitizer with at least 60% alcohol.

· Avoid close contact with people who are sick.

· Avoid touching your eyes, nose, and mouth.

· Clean and disinfect frequently touched objects and surfaces within their place of residence.

Beyond simply monitoring the situation, CereScan is taking active measures to prevent the spread of COVID-19. These additional measures include:

· Limiting family or friends who might visit during an appointment.

· Added protective equipment for staff and clinicians.

· Cleaning and disinfecting patient injection room and camera room after each use.

· Cleaning and disinfecting all areas of the clinic on a nightly basis.

These above measures, along with other CereScan policy updates commensurate with the evolving global knowledge of COVID-19, will continue to provide a safe, comfortable, and welcoming place for patients to receive their evaluations.

Symptoms of COVID-19

Most people with the virus will only develop mild symptoms. Those with underlying medical conditions and the elderly are at greater risk for more severe symptoms. Symptoms can appear anywhere from 2-14 days after exposure and can include:

· Respiratory symptoms

· Fever

· Cough

· Shortness of breath

· Breathing difficulties

A CereScan team member will contact you 2 days prior to your appointment to complete a brief questionnaire. If you are experiencing any mild flu-like symptoms, it could be in the best interest of everyone involved to reschedule your appointment. If you are experiencing any of the above symptoms in a severe manner, please call your state or local health departments for testing (ensuring to call ahead of any trip to the emergency room to let them know you are coming).

Understanding and Background of COVID-19

Coronaviruses are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). COVID-19 is a new strain that was discovered in late 2019 in Asia and has spread to more than 100 countries at the time of this writing – the United States being one of the more recent countries to contract it. As with the common cold or seasonal flu, COVID-19 is transmitted through touch. This includes touching exposed surfaces or objects with the virus and then touching one’s eyes, or mouth, or the inhalation of airborne water droplets from a carrier of COVID-19.


At the CereScan clinic our patients are our number one priority. Period! We will continue to remain vigilant to prevent the spread of COVID-19 while ensuring that we do not disrupt your continuity of care. Because of our patient-centric culture, from our building to patient evaluation, we strongly believe that CereScan is the absolute safe place for receiving medical care. Come see us with supreme confidence. Rest assured, your continued confidence in CereScan is well placed.

John Kelley

Chief Executive Officer and Chairman, CereHealth Corp.

John Kelley Forbes CereMetrix CereScan

CereScan on Forbes: What Radiology Tech Can Learn From Baseball’s Electronic Strike Zone Debate 

Last baseball season when the electronic strike zone idea was once again hotly debated, the striking similarities between the issues baseball and radiology face – accuracy, objectivity, efficiency – became glaringly obvious.

The idea of using technology to increase game consistency and accuracy is a controversial one. The same could be said of the use of automated technologies in radiology. Radiologists fear the introduction of automation and machine learning technologies could make their jobs extinct. However, striking the right balance between human intellect and technology advancements is key to a more successful future.

Whether you’re a physician or an umpire, machine intelligence can provide the information needed to make better, faster decisions. In his latest article, John Kelley, CEO of CereScan and notable tech industry leader, takes a deep dive into how together human and machine have the potential to change the world of healthcare, baseball and beyond.

What Radiology Tech Can Learn From Baseball’s Electronic Strike Zone Debate

Forbes.comJohn Kelley Forbes CereMetrix CereScan – Growing up in St. Louis — arguably the home of the best fanbase in baseball — I quickly became an avid student and player of America’s favorite pastime. Every guy I grew up with playing baseball enjoyed dissecting the technicalities of the game and all the moving parts that come together to form each and every play.

Take the pitcher and the hitter, for example. The matchup would seem to be a simple process of throwing a ball in different ways and having a hitter attempt to successfully make contact. In reality, there is a very complex set of non-verbal processes communicated to each player in the field before any pitch is thrown… Read the full article.

CereScan on Using Data Analytics to Fight the Opioid Crisis

The opioid crisis statistics are alarming: Drug overdoses, most of which are related to opioids, killed over 64,000 people in the United States last year — an increase of 21% over 2015. Disturbing as those numbers are, understanding the data behind opioid addiction, and analyzing the overwhelming information being collected is critical to fighting the drug crisis.

In the article title “Using Big Data Medical Analytics to Address the Opioid Crisis,” CereScan CEO, John Kelley, discusses how data analytics can and must become a key component in the effort to end the opioid epidemic.

“We’ve all seen the statistics: Drug overdoses, most of which are related to opioids, killed over 64,000 people in the United States last year — an increase of 21% over 2015, according to the CDC. The New York Times just reported that fentanyl has overtaken the top spot from heroin as the leading cause of these deaths. Almost as chilling, there are an estimated 2 million prescription opioid addicts, putting a squeeze on the economy to the tune of more than $75 billion annually.

The national opioid crisis is a dilemma of dichotomies. There are challenges with both prescription and illicit drugs. The solutions must consist of efforts that realistically can reduce the number of people who become addicts in the first place, as well as cure those who do…”

Read the full article on


Just Like Wine, No Two Brains are Alike

Most physicians I know believe in the health properties of wine when taken in moderation. It improves stress levels, lowers risk of stroke and, depending on the research you read, may even help with arterial sclerosis. If nothing else, it helps doctors relax and gives them something other than medicine to talk about.

Wine was central to my thesis when I recently participated in Singularity University’s Global Forum, a world-class collection of thinkers, leaders and doers who educate, influence and inspire other on the front lines of technical innovation. I was a member of the Breakthrough Panel, which included other leaders in neuroscience.

I used an analogy to show how, like the human brain, no two vintages of wine are the same but they do have similarities that connect them in a variety of ways. An experienced sommelier is trained to pick up on the subtle differences between wines, just like a physician is trained to identify the subtle differences between medical conditions.

Addressing the uniqueness and complexity in identifying abnormalities in the human brain, which has been greatly enhanced through the use of breakthrough technology and advanced data analytics, is much like addressing the subtleties of different wines. Instead of an aficionado using his or her trained nose and palate, doctors and other medical specialists need to apply new technologies to collect data about traumas, symptoms, imaging, genomics and more on one side, and help deliver faster and more accurate diagnoses for conditions ranging from Alzheimer’s to strokes.

I cited recent literature and use cases, showing the power of data in its objective measurement and predictive capabilities. Put simply, biomedical programs have a treasure trove of data that can be mined to assist in the identification of conditions and the subsequent prescription of therapies. because of big data analytics, physicians can know dramatically more about their patients and directly translate that knowledge into improved decision making and results.

The bottom line from the Global Forum is that collaboration and data sharing drives progress and innovation in the medical fields and beyond. For the wine lover, this means a future of good drinks and even better medicine.

John A. Kelley, Jr., is Chairman and CEO of CereScan, a functional brain diagnostics company headquartered in Denver.